BIF acquires shares in Goodair

16 February 2024

Booster Innovation Fund adds Goodair to its investment portfolio.

Booster is pleased to announce the addition of Goodair (My Better Breathing Limited), to the Booster Innovation Fund (BIF) portfolio.

Goodair operates in the medical device part of the healthcare sector. It specialises in the development of mechanical breathing technologies. Their device, Goodair Nosebuds, provides a non-invasive, non-drug, effective nasal congestion solution, which aims to improve breathing by keeping the patient's nose clear and open. Goodair was formed in 2021, and is classified as a seed stage business, with its technology origins being from Auckland University of Technology.

BIF will make a cash investment of $100,000. Following this transaction, Goodair will represent 0.5% of BIF’s investment portfolio which supports over 35 companies, and with a net asset value of over $19.5 million.

Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of the process described in the fund’s Product Disclosure Statement (PDS) that is available at www.booster.co.nz

For further information regarding BIF visit https://www.booster.co.nz/booster-investments/booster-innovation-fund.aspx





For more information, please contact:
Gary Scott
Company Secretary
Booster Investment Management Limited
04 8944300


About Booster
Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of the Booster Group which has been helping New Zealanders save since 1998. The group currently administers superannuation and investment funds of over $6 billion on behalf of more than 190,000 New Zealanders.
BIF is a managed investment fund that invests in early-stage companies founded on intellectual property originated or developed in New Zealand.
For more information, including a copy of the Product Disclosure Statement, please visit www.booster.co.nz

---

Announcement PDF